FDA Inspection 952157 — Northwind Pharmaceuticals LLC

Northwind Pharmaceuticals LLC — FEI 1831143

The FDA completed an inspection of Northwind Pharmaceuticals LLC on December 9, 2015 in Indianapolis, IN. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 9, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
126621 CFR 211.42(d)Penicillin processing area not kept separate